Certified by Founder Lodge
CancerIQ
United States - Chicago, Illinois
START UP
1 Disclosed Funding Rounds $14,000,000
0 Participating Investments
-
Founded date
2013
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
About Us
CancerIQ helps providers use genetic information to predict, pre-empt, and prevent disease - starting with cancer. By making is easier to identify patients at risk, offer a genetic
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| March, 04 ,2022 | Series B | $14,000,000 |
Amgen
McKesson Ventures
HealthX Ventures
Patchwork Health
Abridge
Salvo Health
CareBridge
Health Note
CRESS | $234,000 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
